Abstract
Travellers’ diarrhoea caused by enteric protozoa like Entamoeba histolytica is among the most common protozoan diseases in developing countries. In developing countries, amoebiasis is the second most prevalent protozoan disease. This protozoan parasite is often known to coexist as a part of the normal gut microbiota. It is estimated that around 50–60 % of population in developing countries might be harbouring Entamoeba in an asymptomatic manner. Due to physiological perturbation or upon immuno-compromise, it can become virulent and then cause diarrhoea, bloody stools and may invade other organs if left untreated. Nitroimidazole drugs, namely metronidazole and tinidazole, are widely used to treat protozoan infections. These drugs often show dose-dependent side effects. With emerging antibiotic resistance, novel therapeutics to prevent parasitic infections is required. This study aims to study effect of probiotics on prevention of Amoebiasis. In this study, we have investigated the effect of selected probiotics on the growth of Entamoeba. From the list of probiotics being currently used, five bacterial strains were selected for testing. These probiotic strains were co-cultured with Entamoeba, and their effect on Entamoeba proliferation was checked. Of the five probiotics chosen, individual treatments of Lactobacillus casei and Enterococcus faecium showed a significant reduction of up to 71 % in parasite survival only at higher CFUs. When the two probiotics were used in combination, the percentage of survival reduced gradually further to 80 % at a total CFU of 109 cells/ml of bacteria. The study lays the foundation for providing cost-effective prophylactic treatment for amoebiasis without the overuse of antibiotics.
Similar content being viewed by others
References
Huston CD, Petri WA Jr (2001) Emerging and reemerging intestinal protozoa. Curr Opin Gastroenterol 17(1):17–23
Mortimer L, Chadee K (2010) The immunopathogenesis of Entamoeba histolytica. Exp Parasitol 126(3):366–380. doi:10.1016/j.exppara.2010.03.005
Savas-Erdeve S, Gokay S, Dallar Y (2009) Efficacy and safety of Saccharomyces boulardii in amebiasis-associated diarrhea in children. Turk J Pediatr 51(3):220–224
Haque R, Huston CD, Hughes M, Houpt E, Petri WA Jr (2003) Amebiasis. N Engl J Med 348(16):1565–1573. doi:10.1056/NEJMra022710
Andersson KE (1981) Pharmacokinetics of nitroimidazoles. Spectrum of adverse reactions. Scand J Infect Dis Suppl 26:60–67
Rani R, Murthy RS, Bhattacharya S, Ahuja V, Rizvi MA, Paul J (2006) Changes in bacterial profile during amebiasis: demonstration of anaerobic bacteria in ALA pus samples. Am J Trop medicine and hygiene 75(5):880–885
Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, Kalantzopoulos G, Tsakalidou E, Mentis A (2004) In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol 70(1):518–526
Pillai A, Nelson R (2008) Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database of Syst Rev (1):CD004611. doi:10.1002/14651858.CD004611.pub2
Goyal N, Tiwari RP, Shukla G (2011) Lactobacillus rhamnosus GG as an effective probiotic for murine giardiasis. Interdiscipl Perspect Infect Dis 2011:795219. doi:10.1155/2011/795219
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME (2014) Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11(8):506–514. doi:10.1038/nrgastro.2014.66
Travers MA, Florent I, Kohl L, Grellier P (2011) Probiotics for the control of parasites: an overview. J Parasitol Res 2011:610769. doi:10.1155/2011/610769
Mansour-Ghanaei F, Dehbashi N, Yazdanparast K, Shafaghi A (2003) Efficacy of Saccharomyces boulardii with antibiotics in acute amoebiasis. World J Gastroenterol 9(8):1832–1833
Rigothier MC, Maccario J, Gayral P (1994) Inhibitory activity of Saccharomyces yeasts on the adhesion of Entamoeba histolytica trophozoites to human erythrocytes in vitro. Parasitol Res 80(1):10–15
Gomi A, Iino T, Nonaka C, Miyazaki K, Ishikawa F (2015) Health benefits of fermented milk containing Bifidobacterium bifidum YIT 10347 on gastric symptoms in adults. J Dairy Sci 98(4):2277–2283. doi:10.3168/jds.2014-9158
Divyashri G, Krishna G, Muralidhara Prapulla SG (2015) Probiotic attributes, antioxidant, anti-inflammatory and neuromodulatory effects of Enterococcus faecium CFR 3003: in vitro and in vivo evidence. J Med Microbiol 64(12):1527–1540. doi:10.1099/jmm.0.000184
Dietrich CG, Kottmann T, Alavi M (2014) Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea. World J Gastroenterol 20(42):15837–15844. doi:10.3748/wjg.v20.i42.15837
De Montijo-Prieto S, Moreno E, Bergillos-Meca T, Lasserrot A, Ruiz-Lopez MD, Ruiz-Bravo A, Jimenez-Valera M (2015) A Lactobacillus plantarum strain isolated from kefir protects against intestinal infection with Yersinia enterocolitica O9 and modulates immunity in mice. Res Microbiol 166(8):626–632. doi:10.1016/j.resmic.2015.07.010
Chew SY, Cheah YK, Seow HF, Sandai D, Than LT (2015) Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 exhibit strong antifungal effects against vulvovaginal candidiasis-causing Candida glabrata isolates. J Appl Microbiol 118(5):1180–1190. doi:10.1111/jam.12772
Freedman SB, Sherman PM, Willan A, Johnson D, Gouin S, Schuh S, Pediatric Emergency Research C (2015) Emergency department treatment of children with diarrhea who attend day care: a randomized multidose trial of a Lactobacillus helveticus and Lactobacillus rhamnosus combination probiotic. Clin Pediatr (Phila) 54(12):1158–1166. doi:10.1177/0009922815569200
Wang Z, Samuelson J, Clark CG, Eichinger D, Paul J, Van Dellen K, Hall N, Anderson I, Loftus B (2003) Gene discovery in the Entamoeba invadens genome. Mol Biochem Parasitol 129(1):23–31
Ehrenkaufer GM, Weedall GD, Williams D, Lorenzi HA, Caler E, Hall N, Singh U (2013) The genome and transcriptome of the enteric parasite Entamoeba invadens, a model for encystation. Genome Biol 14(7):R77. doi:10.1186/gb-2013-14-7-r77
Dmj C, Rogosa M, Sharpe ME (1960) A medium for the cultivation of Lactobacilli. J Appl Bacteriol 23:130–135
Perez PF, Minnaard J, Rouvet M, Knabenhans C, Brassart D, De Antoni GL, Schiffrin EJ (2001) Inhibition of Giardia intestinalis by extracellular factors from Lactobacilli: an in vitro study. Appl and Environ Microbiol 67(11):5037–5042. doi:10.1128/AEM.67.11.5037-5042.2001
Diamond LS, Harlow DR, Cunnick CC (1978) A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg 72(4):431–432
Singh M, Sharma S, Bhattacharya A, Tatu U (2015) Heat shock protein 90 regulates encystation in Entamoeba. Front Microbiol 6:1125. doi:10.3389/fmicb.2015.01125
Pallavi R, Roy N, Nageshan RK, Talukdar P, Pavithra SR, Reddy R, Venketesh S, Kumar R, Gupta AK, Singh RK, Yadav SC, Tatu U (2010) Heat shock protein 90 as a drug target against protozoan infections: biochemical characterization of HSP90 from Plasmodium falciparum and Trypanosoma evansi and evaluation of its inhibitor as a candidate drug. J Biol Chem 285(49):37964–37975. doi:10.1074/jbc.M110.155317
Heyman M, Menard S (2002) Probiotic microorganisms: how they affect intestinal pathophysiology. Cell Mol Life Sci: CMLS 59(7):1151–1165
Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9(5):313–323. doi:10.1038/nri2515
Bansal D, Malla N, Mahajan RC (2006) Drug resistance in amoebiasis. Indian J Med Res 123(2):115–118
Dinleyici EC, Eren M, Yargic ZA, Dogan N, Vandenplas Y (2009) Clinical efficacy of Saccharomyces boulardii and metronidazole compared to metronidazole alone in children with acute bloody diarrhea caused by amebiasis: a prospective, randomized, open label study. Am J Trop Med Hyg 80(6):953–955
Acknowledgments
Funding support from Department of Biotechnology, Government of India and DBT-IISc Partnership Grant is acknowledged. Funding from Council for Scientific and Industrial Research, India, is acknowledged by MS.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Sarjapuram, N., Mekala, N., Singh, M. et al. The Potential of Lactobacillus casei and Entercoccus faecium Combination as a Preventive Probiotic Against Entamoeba . Probiotics & Antimicro. Prot. 9, 142–149 (2017). https://doi.org/10.1007/s12602-016-9232-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12602-016-9232-z